Join our free AML Hub webinar in November!
October 15, 2025
Understanding the differences between FLT3-ITD and -TKD mutations in AML: Implications for clinical practice
Date: November 19, 2025, 17:00–18:00 GMT
Register: webinar.aml-hub.com
Experts Gail Roboz, Jorge Sierra, and Jorge Cortes will dissect the biological and clinical differences between FLT3-ITD and FLT3-TKD mutations in acute myeloid leukemia, translating molecular insights into practical treatment strategies.
Learn how mutation subtype influences prognosis, therapy choice, and resistance management followed by a live Q&A.
Please share with any individuals within your network who might benefit from joining this discussion.
This independent educational activity is supported by Daiichi Sankyo. All content is developed independently by the faculty. The funder is allowed no influence on the content.
If you are interested in supporting the AML Hub in creating further educational opportunities such as this one, please contact Partnerships@ScientificEducationSupport.com.
